Race against time: new drug could extend stroke treatment window
NCT ID NCT07389460
Summary
This study is testing if giving a clot-dissolving drug (rhPro-UK) by IV before a standard clot-removal surgery helps people recover better from a major stroke. It focuses on patients who arrive for treatment 4.5 to 24 hours after their stroke symptoms began, which is later than the usual window. The main goal is to see if this two-step approach leads to more people living independently 90 days after their stroke, while carefully checking for risks like brain bleeding.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Henan Provincial People's Hospital
Zhengzhou, Henan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Loudi Central Hospital
Loudi, Hunan, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Qinghai Provincial People's Hospital
Xining, Qinghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanxi Cardiovascular Hospital
Taiyuan, Shanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Shihezi University
Shihezi, Xinjiang Uygur Autonomous Region, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Hospital of Lanzhou University
Lanzhou, Gansu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second Hospital of Dalian Medical University
Dalian, Liaoning, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Third Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xuanwu Hospital Capital Medical University
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.